Læknablaðið - 15.03.2006, Síða 46

ASPIRIW(TIOTROPIUM)
Meira loft í lungun
SPIRIVA"
er grunnurinn í
meðhöndlun á LLT12)
Frelsi
& Minnkar mæði við áreynslu3’
A Eykur úthald við áreynslu31
A Fækkar versnunum og innlögnum
vegna þeirra4’
A Eykur lífsgæði sjúklings5’
leimildir: I) Medicinsk Kompendium 2004; bis 1331. 2) Tashkin es ai. Review.The Role of Long-Acting Bronchodilators in the Management of Stable COPD. CHEST 2004;125:249-259. 3) O'Donnell et al. Effects of tiotropium on lung hyperinllation.
lyspnoea and exercise tolerance in COPD. Eur RespirJ 2004:23:832-040. 4) Casaburi et al.A long-term evaluation of once daily Inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19:217-224. 5) Vincken et al. Improved health
lUtcomes in patients with COPD during I years treatment with tiotropium. Eur Respir J 2002; 19:209-216.
UmboðsaðiliiVistor hf.
Hörgatúni 2, 210 Garðabær
Sími: 53S 7000, www.pfizer.is Sérlyfjatexti á bls. 241
Boehringer
Ingelheim